Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

For years, obesity was often seen as a result of poor lifestyle choices. However, experts now suggest that biological factors ...

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...